Cite

HARVARD Citation

    Dercle, L. et al. (2016). Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy. European journal of cancer. pp. 33-42. [Online]. 
  
Back to record